Fundz

Virax Biolabs Group Ltd reported raising $4 Million in an initial SEC Form D filing, from an offering of $4 Million

PUBLIC · VRAXMar 15, 2023

Amount Raised

$4 Million

$4 Million sold, per SEC Form D (first sale Mar 10, 2023)

Round Type

Venture

LanarkshireManufacturingBiotechnologyHealth CareTherapeutics

Who to call at Virax Biolabs, and when

A new round usually means Virax Biolabs is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Virax Biolabs raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Virax Biolabs, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Virax Biolabs. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Virax Biolabs

Location

Lanarkshire, Scotland, United Kingdom

About

Virax Biolabs Group Limited is an innovative biotech company founded in 2013 that focuses on detecting immune responses and diagnosing viral diseases, distributing a range of in-vitro diagnostic test kits while developing proprietary T-Cell Test technology aimed at providing an immunology profiling platform to assess individual immune risk against major global viral threats, including COVID-19, Monkeypox, Hepatitis B, Malaria, Herpes, and Human Papillomavirus.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Virax Biolabs raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsJames F., Founder & Chief Executive Officer hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Virax Biolabs's next move

See what Strategic adds

Virax Biolabs raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.